Compare JPMorgan Equity Premium Income ETF (JEPI) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Equity Premium Income ETF vs Kymera Therapeutics Inc. Common Stock — how do they compare? JPMorgan Equity Premium Income ETF trades at $56.96 (market cap $45.63B), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: JPMorgan Equity Premium Income ETF is far larger — about 5.1× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Equity Premium Income ETF for 58 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| JEPI | KYMR | |
|---|---|---|
Market Cap | $45.63B | $8.88B |
Volume | 4,550,946 | 1,028,790 |
Sector | Income / Options Overlay | Health |
52-Week High | $59.88 | $127.31 |
52-Week Low | $55.29 | $55.80 |
Typical Hold Time | 58 Days | 0 Days |
Enterprise Value | — | $8.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JEPI trades at $56.93, showing minimal daily movement with a slight decline of 0.05%. The ETF maintains a bullish technical outlook with strong moving average signals, though oscillators suggest neutral momentum. Recent dividend distributions of $0.34-$0.37 demonstrate consistent income generation, while financial media coverage highlights JEPI's role in income-focused portfolios and its appeal to retirees seeking monthly distributions.
JEPI presents as a stable income vehicle with reliable dividend payments, though valuation metrics remain unavailable for fundamental assessment. The ETF's covered call strategy provides downside protection but may limit upside potential during strong market rallies. Key risks include interest rate sensitivity and the trade-off between income generation and capital appreciation in rising markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
